바로가기
메인메뉴로 바로가기
콘텐츠 바로가기
하단메뉴로 바로가기
패밀리사이트 바로가기


진료과

  • 암병원(강남)-종양내과, 폐암센터, 유방암센터, 위·식도암센터, 췌·담도암센터, 전립선암센터, 간암센터

전문진료분야

  • <종양내과> 유전자 분석을 통한 개인 맞춤 표적 치료 전문

진료시간표

인터넷진료예약
의사시간표
진료시간
오전 암병원 암병원
오후 암병원 암병원

교육 및 임상 경력

  • 1990  연세의대  세브란스병원  인턴  수련
  • 1991~1994  연세의대  세브란스병원  내과  수련의 
  • 1995~1997  연세  암센터  종양내과  강사 
  • 1998~2003  연세의대  용인세브란스병원  종양내과  조교수
  • 2004~2010  연세의대  강남세브란스병원  종양내과  부교수 
  • 2007~2009  미국  MD  Anderson  암센터  교환교수 
  • 2011~  현재  연세의대  강남세브란스병원  종양내과  교수,  혈액종양내과장,  암전문병원  진료부장

학술관련경력

  • 미국 임상 암 학회 정회원
  • 유럽 임상 암 학회 정회원
  • 대한 암 학회 평생 회원
  • 대한 항암 화학 요법 학회 정회원
  • 미국 Cancer 지 Reviewer
  • 미국 임상 암학회 회원
  • 미국 암 연구 학회 회원

주요 관심분야

  • 위암, 대장암, 간담췌암 등의 소화기암과 전이암의 표적치료

학력사항

  • 연세대학교 의과대학 졸업 (1990)
  • 연세대학교 의과대학 석사 (1994)
  • 연세대학교 의과대학 박사 (1997)

논문

  • Gene Expression Signature-Based Prognostic Risk Score in Gastric Cancer. Clin Cancer Res. 2011 Apr 1;17(7):1850-1857.
  • Outcome of Adjuvant Therapy for Gallbladder Cancer. Oncology. 2010 Dec 31;79(3-4):168-173
  • Oxaliplatin Combined with Continuous Infusion of 5-Fluorouracil as First-Line Chemotherapy in Patients with Metastatic or Recurrent Gastric Adenocarcinoma
  • Chemotherapy 55 4:200~206,2009
  • Phase II trial of oxaliplatin combined with leucovorin and fluorouracil for rccurrent/metastatic biliary tract carcinoma
  • Anti-Cancer Drugs 19:631~635,2008
  • A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
  • Cancer Chemotherapy And Pharmacology 62:763~768,2008
  • Salvage chemotherapy with docetaxel and epirubicin for advanced/metastatic gastric cancer
  • Oncology 73 1-2:2~8,2008
  • Diagnostic application of serum proteomic patterns in gastric cancer patients by ProteinChip surface-enhanced laser desorption/ionization time-of-flight mass spectrometry
  • INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS 22 4:281~286,2007
  • A phase II study of capecitabine combined with gemcitabine in patients with advanced gallbladder carcinoma
  • YONSEI MEDICAL JOURNAL 46 4:526~531,2005
  • Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma
  • CANCER 104:2753~2758,2005
  • A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer
  • ANNALS OF ONCOLOGY 15:1344~1347,2004
  • Observation of Cabibbo-suppressed and W exchange Lambda_c baryon decays
    PHYSICS LETTERS B 524/0 :33-43,2002
  • Evaluation of E1b gene-attenuated replicating adenoviruses for cancer gene therapy
    CANCER GENE THERAPY 9/9 :725-736,2002
  • Phase II Study of Gemcitabine and Vinorelbine as Second-Line Chemotherapy in Non-small Cell Lung Cancer
    CANCER RESEARCH AND TREATMENT 35/4 :294-298,2003
  • A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer
    ANNALS OF ONCOLOGY 15/ :1344-1347,2004
  • A phase II study of capecitabine combined with gemcitabine in patients with advanced gallbladder carcinoma
    YONSEI MEDICAL JOURNAL 46/4 :526-531,2005
  • Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma
    CANCER 104/ :2753-2758,2005
  • 간세포암 환자에서 간동맥 화학색전술 후 발생한 급성 간부전의 위험인자
    대한내과학회지(korean Journal of medcine) 69/6 :622-630,2005
  • Preoperative staging accuracy of multidetector row computed tomography for extrahepatic bile duct carcinoma
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY 30/3 :362-367,2006
  • 9-cis retinoic acid induces insulin-like growth factor binding protein-3 through DR-8 retinoic acid responsive elements
    CANCER BIOLOGY & THERAPY 5/6 :586-592,2006
  • 임신 중 발견된 뇌전이를 동반한 유방의 원발성악성림프종 1예
    대한혈액학회지 41/3 :8-8,2006
  • Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer
    ONCOLOGY REPORTS 16/ :1205-1210,2006
  • Docetaxel-induced onycholysis: The role of subungual hemorrhage and suppuration
    YONSEI MEDICAL JOURNAL 48/1 :124-126,2007
  • Non-Hodgkin's lymphoma of the sphenoid sinus presenting as isolated oculomotro never palsy
    World Journal of Surgical Oncology 5/ :86-,2007
  • Diagnostic application of serum proteomic patterns in gastric cancer patients by ProteinChip surface-enhanced laser desorption/ionization time-of-flight mass spectrometry
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS 22/4 :281-286,2007
  • A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
    Cancer Chemotherapy And Pharmacology 62/ :763-768,2008
  • Salvage chemotherapy with docetaxel and epirubicin for Advanced/Metastatic gastric cancer
    Oncology 73/1-2 :2-8,2008
  • Phase II trial of oxaliplatin combined with leucovorin and fluorouracil for recurrent/metastatic biliary tract carcinoma
    Anti-Cancer Drugs 19/6 :631-635,2008
  • Oxaliplatin Combined with Continuous Infusion of 5-Fluorouracil as First-Line Chemotherapy in Patients with Metastatic or Recurrent Gastric Adenocarcinoma
    Chemotherapy 55/4 :200-206,2009
  • Outcome of Adjuvant Therapy for Gallbladder Cancer
    Oncology 79/3-4 :168-173,2010
  • Prognostic Biomarkers for Esophageal Adenocarcinoma Identified by Analysis of Tumor Transcriptome
    PLoS One 5/11 :e15074-,2010
  • Gene Expression Signature-Based Prognostic Risk Score in Gastric Cancer
    CLINICAL CANCER RESEARCH 17/7 :1850-1857,2011
  • Gene Expression Signature Analysis Identifies Vorinostat as a Candidate Therapy for Gastric Cancer
    PLOS ONE 6/9 :1-10,2011
  • Antifibrotic effects of magnesium lithospermate B on hepatic stellate cells and thioacetamide-induced cirrhotic rats
    EXPERIMENTAL AND MOLECULAR MEDICINE 43/6 :341-349,2011
  • Prognostic Factors of Second and Third Line Chemotherapy Using 5-FU with Platinum, Irinotecan, and Taxane for Advanced Gastric Cancer
    Cancer Research and Treatment 43/4 :236-243,2011
  • 복강 내에서 발견된 기관지원성낭종 내의 선암 1예
    대한내과학회지 82/3 :374-377,2012
  • Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
    LANCET 379/9813 :315-321,2012
  • AMPK alpha Modulation in Cancer Progression: Multilayer Integrative Analysis of the Whole Transcriptome in Asian Gastric Cancer
    CANCER RESEARCH 72/10 :2512-2521,2012
  • Overexpression of the M2 isoform of pyruvate kinase is an adverse prognostic factor for signet ring cell gastric cancer
    WORLD JOURNAL OF GASTROENTEROLOGY 18/30 :4037-4043,2012
  • Comparison of Two Inflammation-Based Prognostic Scores in Patients with Unresectable Advanced Gastric Cancer
    ONCOLOGY 83/5 :292-299,2012
  • Treatment Outcome of Patients with Anaplastic Thyroid Cancer: A Single Center Experience
    YONSEI MEDICAL JOURNAL 53/2 :352-357,2012
  • Thioredoxin and thioredoxin-interacting protein as prognostic markers for gastric cancer recurrence
    WORLD JOURNAL OF GASTROENTEROLOGY 18/39 :5581-5588,2012
  • Design of precise third-line therapy for gastric cancer: target or chemotherpy?
    The Korean Journal of Internal Medicine 28/3 :297-299,2013
  • 성인에서 천미부 기형종의 선암으로 전환 1예
    대한내과학회지 85/1 :101-105,2013
  • Overexpression of miR-196b and HOXA10 characterize a poor-prognosis gastric cancer subtype
    WORLD JOURNAL OF GASTROENTEROLOGY 19/41 :7078-7088,2013
  • Clinicopathologic Implications of the BRAFV600E Mutation in Papillary Thyroid Cancer : A Subgroup Analysis of 3130 Cases in a Single Center
    THYROID 23/11 :1423-1430,2013
  • Molecular Diagnosis for Personalized Target Therapy in Gastric Cancer
    Journal of Gastric Cancer 13/3 :129-135,2013
  • Targeted therapy in gastric cancer: Personalizing cancer treatment based on patient genome
    WORLD JOURNAL OF GASTROENTEROLOGY 20/8 :2042-2050,2014
  • Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
    LANCET 383/9911 :31-39,2014
  • Clinical practice guidelines for gastric cancer in Korea: An evidence-based approach
    Journal of Gastric Cancer 14/2 :87-104,2014
  • Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer.
    CANCER RESEARCH AND TREATMENT 47/2 :266-273,2015
  • 혈액투석 환자에서 발생한 카포시육종의 Pazopanib 치료 증례
    대한내과학회지 89/1 :113-116,2015
  • Comparison of surgery plus chemotherapy and palliative chemotherapy alone for advanced gastric cancer with krukenberg tumor
    CANCER RESEARCH AND TREATMENT 47/4 :697-705,2015
  • Phase II trial of dacomitinib in patients with HER2-positive gastric cancer
    GASTRIC CANCER 19/4 :1,095-1,103,2016
  • Overexpression of Endoplasmic Reticulum Oxidoreductin 1- ERO1L Is Associated with Poor Prognosis of Gastric Cancer
    CANCER RESEARCH AND TREATMENT 48/4 :1,196-1,209,2016
  • Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial
    JOURNAL OF CLINICAL ONCOLOGY 34/23 :2,728-2,735,2016
  • Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01)
    CANCER 123/11 :1,958-1,964,2017
  • Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data
    Journal of Gastric Cancer 17/2 :132-144,2017
  • Efficacy of Sequential Ipilimumab Monotherapy versus Best Supportive Care for Unresectable Locally Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer
    CLINICAL CANCER RESEARCH 23/19 :5,671-5,678,2017
  • Survival analysis based on human epidermal growth factor 2 status in stage Ⅱ-Ⅲ gastric cancer
    WORLD JOURNAL OF GASTROENTEROLOGY 23/41 :7407-7414,2017
  • Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
    LANCET 390/10111 :2,461-2,471,2017
  • Efficacy of adjuvant chemotherapy for completely resected stage IB non-small cell lung cancer: a retrospective study
    JOURNAL OF THORACIC DISEASE 10/4 :2,279-2,287,2018
  • Subgroup analysis of East Asian patients in REGARD: A phase III trial of ramucirumab and best supportive care for advanced gastric cancer
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 14/3 :204-209,2018
  • Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG).
    GASTRIC CANCER 21/5 :819-830,2018

조재용

진료철학
종양내과에서는 자체적인 연구시설을 갖추고, 미국 유수의 암센터와 유전자 검사 기관과 연계하여 종양의 진행, 예후와 관련이 있는 유전자에 대한 연구를 진행하고 있습니다. 환자분의 종양조직과 혈액의 유전자를 분석하여 각 개인에게 가장 적절한 맞춤 치료를 시행함으로써 국제적으로 가장 우수한 암치료를 제공하고자 합니다. 아울러 부작용 없는 치료를 통하여 환자의 삶의 질을 최우선으로 향상시키고자 노력하고 있습니다.

콘텐츠 처음으로 이동

네크워크 링크안내/사이트 정보